Solius raises investment from Human Longevity Inc. to test UV kiosks' vitamin D boost as possible way to reduce COVID-19 severity
Seattle startup Solius, which makes ultraviolet light therapy kiosks claimed to raise vitamin D, received new investment from Human Longevity Inc. as it explores clinical trials to test whether boosting vitamin D could reduce COVID-19 severity, following research that found correlations between low vitamin D and higher COVID-19 mortality.